International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: April 2024

Volume 9 | Issue 4

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Effectiveness of Inhaled Steroids in Post COVID Cough
Authors Name: Dr. Sudhir Bhandari , Dr. Ajeet Singh , Dr. Govind Rankawat
Unique Id: IJSDR2203020
Published In: Volume 7 Issue 3, March-2022
Abstract: Background: Coronavirus disease 2019 can leads to persistent cough which may need special attention for better compliance of patients. We aimed to discuss the effect of inhaled steroids (Budesonide) in treatment of post COVID persistent cough and to know role of inhaled steroids in early recovery of COVID-19 patients. Methods: This retrospective observational case-control study included a total of 120 admitted patients of COVID-19 complaining of persistent cough after exclusion of another known identifiable causes. 60 patients had history of inhaled steroids for treatment of persistent cough while another 60 patients treated with standard of care treatment taken as a control group. The patient’s data concerning demography, clinical profile, severity of disease, duration of illness, oxygen support, and outcome were extracted from their medical records. All collected data were tabulated, compiled, and analyzed to establish the possible causality of pneumothorax. Results: Patients of both groups had matched demographic, clinical symptoms, and comorbid status. Patients treated with inhaled steroids along with standard of care treatment had significant fast recovery (4.85 ± 3.94 days) as compared to control group (7.68 ± 5.43 days) with P=0.0014. Patients of inhaled steroids group also had early wean off from oxygen support (5.21 v/s 7.82 days), early discharge from hospital (6.54 days’ v/s 8.87 days), and lesser alleviation of COVID-19 symptoms (8.33% v/s 21.67%) with P<0.05 Conclusion: This study concluded that the inhaled budesonide along with standard of care treatment helpful to relieve post COVID persistent cough. Beside early relief in cough, inhaled steroids also useful in early withdrawal of oxygen support and early discharge from hospital.
Keywords: COVID-19, Inhaled steroids, Post COVID cough
Cite Article: "Effectiveness of Inhaled Steroids in Post COVID Cough", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.7, Issue 3, page no.138 - 142, March-2022, Available :http://www.ijsdr.org/papers/IJSDR2203020.pdf
Downloads: 000337073
Publication Details: Published Paper ID: IJSDR2203020
Registration ID:200125
Published In: Volume 7 Issue 3, March-2022
DOI (Digital Object Identifier):
Page No: 138 - 142
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview

Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media

Indexing Partner